95
Participants
Start Date
January 23, 2020
Primary Completion Date
March 16, 2023
Study Completion Date
March 16, 2023
Brexpiprazole
Oral tablet; taken once daily
Research site, New York
Richmond Behavioral Associates, Staten Island
Bioscience Research, Mount Kisco
Finger Lakes Clinical Research, Rochester
APG Research, Orlando
Dothan Behavioral Medicine Clinic, Dothan
Access Clinical Trials, Nashville
Research Site, Avon Lake
Research site, Bloomfield Hills
Autism Assessment, Research, Treatment and Services (AARTS) center, Chicago
Research site, Saint Charles
Thompson Center for Autism and Neurodevelopment, Columbia
Alivation, Lincoln
Research site, Lake Charles
The Holloway Group, Inc, Oklahoma City
Cedar Health Research, Dallas
Family Psychiatry of the Woodlands, The Woodlands
Research site, San Antonio
UT Health San Antonio Long School of Medicine, Department of Psychiatry and Behavioral Sciences, San Antonio
Research site, Austin
Southwest Autism Research and Resource Center, Phoenix
Center for Psychiatry and Behavioral Medicine Inc., Las Vegas
Core Clinical Research, Everett
University of California San Francisco, Nancy Friend Pritzker Psychiatry, San Francisco
The Lurie Center for Autism, Lexington
Rutger's-New Jersey Medical Scholl Clinical Research Unit, Newark
For additional information regarding sites, Princeton
Woodstock Research Center, Woodstock
H. Lundbeck A/S
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY